115 related articles for article (PubMed ID: 20231852)
1. CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cells.
Yurchenko MY; Kovalevska LM; Shlapatska LM; Berdova GG; Clark EA; Sidorenko SP
Immunol Cell Biol; 2010 Jul; 88(5):565-74. PubMed ID: 20231852
[TBL] [Abstract][Full Text] [Related]
2. The role of CD150-SH2D1A association in CD150 signaling in Hodgkin's lymphoma cell lines.
Yurchenko MY; Kashuba EV; Shlapatska LM; Sivkovich SA; Sidorenko SP
Exp Oncol; 2005 Mar; 27(1):24-30. PubMed ID: 15812353
[TBL] [Abstract][Full Text] [Related]
3. CD150-mediated Akt signalling pathway in normal and malignant B cells.
Yurchenko M; Shlapatska LM; Romanets OL; Ganshevskiy D; Kashuba E; Zamoshnikova A; Ushenin YV; Snopok BA; Sidorenko SP
Exp Oncol; 2011 Mar; 33(1):9-18. PubMed ID: 21423089
[TBL] [Abstract][Full Text] [Related]
4. The adaptor protein SH2D1A regulates signaling through CD150 (SLAM) in B cells.
Mikhalap SV; Shlapatska LM; Yurchenko OV; Yurchenko MY; Berdova GG; Nichols KE; Clark EA; Sidorenko SP
Blood; 2004 Dec; 104(13):4063-70. PubMed ID: 15315965
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of CD150/SLAMF1 in normal and malignant B cells on the different stages of maturation.
Gordiienko IM; Shlapatska LM; Kovalevska LM; Sidorenko SP
Exp Oncol; 2016 Jun; 38(2):101-7. PubMed ID: 27356578
[TBL] [Abstract][Full Text] [Related]
6. The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling.
Gordiienko I; Shlapatska L; Kholodniuk V; Sklyarenko L; Gluzman DF; Clark EA; Sidorenko SP
PLoS One; 2017; 12(10):e0185940. PubMed ID: 28982149
[TBL] [Abstract][Full Text] [Related]
7. Differential activation and regulation of mitogen-activated protein kinases through the antigen receptor and CD40 in human B cells.
Sakata N; Kawasome H; Terada N; Gerwins P; Johnson GL; Gelfand EW
Eur J Immunol; 1999 Sep; 29(9):2999-3008. PubMed ID: 10508274
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction pathways in Burkitt's lymphoma cell lines BL41 and DG75 with different sensitivity to doxorubicin.
Shlapatska LM; Berdova GG; Kovalevska LM; Kulyk GI; Klein G; Sidorenko SP; Chekhun VF
Exp Oncol; 2004 Sep; 26(3):210-6. PubMed ID: 15494689
[TBL] [Abstract][Full Text] [Related]
9. Isoforms of Jun kinase are differentially expressed and activated in human monocyte/macrophage (THP-1) cells.
Dreskin SC; Thomas GW; Dale SN; Heasley LE
J Immunol; 2001 May; 166(9):5646-53. PubMed ID: 11313405
[TBL] [Abstract][Full Text] [Related]
10. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin's lymphoma: the role of cell surface receptors in regulation of tumor cell fate.
Yurchenko M; Sidorenko SP
Exp Oncol; 2010 Dec; 32(4):214-23. PubMed ID: 21270747
[TBL] [Abstract][Full Text] [Related]
12. Activation of mitogen-activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells.
Kashiwada M; Kaneko Y; Yagita H; Okumura K; Takemori T
Eur J Immunol; 1996 Jul; 26(7):1451-8. PubMed ID: 8766546
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells.
Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T
J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280
[TBL] [Abstract][Full Text] [Related]
14. Expression of SH2D1A in five classical Hodgkin's disease-derived cell lines.
Kis LL; Nagy N; Klein G; Klein E
Int J Cancer; 2003 May; 104(5):658-61. PubMed ID: 12594824
[TBL] [Abstract][Full Text] [Related]
15. Sphinganine causes early activation of JNK and p38 MAPK and inhibition of AKT activation in HT-29 human colon cancer cells.
Ahn EH; Schroeder JJ
Anticancer Res; 2006; 26(1A):121-7. PubMed ID: 16475687
[TBL] [Abstract][Full Text] [Related]
16. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
Liu J; Minemoto Y; Lin A
Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
[TBL] [Abstract][Full Text] [Related]
17. Involvement of alpha-PAK-interacting exchange factor in the PAK1-c-Jun NH(2)-terminal kinase 1 activation and apoptosis induced by benzo[a]pyrene.
Yoshii S; Tanaka M; Otsuki Y; Fujiyama T; Kataoka H; Arai H; Hanai H; Sugimura H
Mol Cell Biol; 2001 Oct; 21(20):6796-807. PubMed ID: 11564864
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4).
Romero X; BenÃtez D; March S; Vilella R; Miralpeix M; Engel P
Tissue Antigens; 2004 Aug; 64(2):132-44. PubMed ID: 15245368
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
[TBL] [Abstract][Full Text] [Related]
20. HSP25 overexpression attenuates oxidative stress-induced apoptosis: roles of ERK1/2 signaling and manganese superoxide dismutase.
Lee YJ; Cho HN; Jeoung DI; Soh JW; Cho CK; Bae S; Chung HY; Lee SJ; Lee YS
Free Radic Biol Med; 2004 Feb; 36(4):429-44. PubMed ID: 14975446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
